Search research articles
Contact Us
Filters
Showing results (51-60 of 123) with videos related to
Page
of 13
Sort By:
Anti-Cancer Drug Design
|
February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNA
A S Clark, M F Stevens, C E Sansom, et al.
Anti-Cancer Drug Design
|
April 1, 1995
Structural studies on bioactive compounds. Part 27. Chemistry of the immunomodulatory agent bropirimine
M F Stevens, G U Baig, E N Gate, et al.
Journal of Medicinal Chemistry
|
July 27, 2001
Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase
D C Chan, C A Laughton, S F Queener, et al.
Anti-Cancer Drug Design
|
April 19, 2002
Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design
K A Croughton, C S Matthews, R J Griffin, et al.
Journal of Medicinal Chemistry
|
November 1, 1989
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor cell line
R J Griffin, M A Meek, C H Schwalbe, et al.
The Journal of Pharmacy and Pharmacology
|
December 1, 1979
The biological and chemical properties of 4-azidobenzenesulphonamide ('azidosulphanilamide') [proceedings]
E A Bliss, T B Brown, M F Stevens, et al.
Biochemical Pharmacology
|
January 1, 1981
Studies of the mode of action of antitumour triazenes and triazines-II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes
A Gescher, J A Hickman, R J Simmonds, et al.
The Journal of Pharmacy and Pharmacology
|
December 1, 1978
alpha-Hydroxylated triazenes: potential active metabolites of anti-tumour dimethyltriazenes [proceedings]
M F Stevens, A Gescher, J A Hickman, et al.
British Journal of Anaesthesia
|
June 24, 2009
Incidental recognition of an aspirated tablet in an oesophagectomized patient
S Braun, R Werdehausen, T Bothur, et al.
DNA Repair
|
December 4, 2014
The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells
F Berardinelli, S Siteni, C Tanzarella, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 123) with videos related to
Sort By:
Page
of 13
Anti-Cancer Drug Design
|
February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNA
A S Clark, M F Stevens, C E Sansom, et al.
Anti-Cancer Drug Design
|
April 1, 1995
Structural studies on bioactive compounds. Part 27. Chemistry of the immunomodulatory agent bropirimine
M F Stevens, G U Baig, E N Gate, et al.
Journal of Medicinal Chemistry
|
July 27, 2001
Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase
D C Chan, C A Laughton, S F Queener, et al.
Anti-Cancer Drug Design
|
April 19, 2002
Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design
K A Croughton, C S Matthews, R J Griffin, et al.
Journal of Medicinal Chemistry
|
November 1, 1989
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor cell line
R J Griffin, M A Meek, C H Schwalbe, et al.
The Journal of Pharmacy and Pharmacology
|
December 1, 1979
The biological and chemical properties of 4-azidobenzenesulphonamide ('azidosulphanilamide') [proceedings]
E A Bliss, T B Brown, M F Stevens, et al.
Biochemical Pharmacology
|
January 1, 1981
Studies of the mode of action of antitumour triazenes and triazines-II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes
A Gescher, J A Hickman, R J Simmonds, et al.
The Journal of Pharmacy and Pharmacology
|
December 1, 1978
alpha-Hydroxylated triazenes: potential active metabolites of anti-tumour dimethyltriazenes [proceedings]
M F Stevens, A Gescher, J A Hickman, et al.
British Journal of Anaesthesia
|
June 24, 2009
Incidental recognition of an aspirated tablet in an oesophagectomized patient
S Braun, R Werdehausen, T Bothur, et al.
DNA Repair
|
December 4, 2014
The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells
F Berardinelli, S Siteni, C Tanzarella, et al.
Page
of 13